Jan Brabender
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
- Surgery 41
- Esophageal Cancer Research and Treatment 35
- Esophageal and GI Pathology 8
-
- Gastric Cancer Management and Outcomes 13
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Kathleen D. Danenberg (26 shared papers)Ralf Metzger (67 shared papers)Peter V. Danenberg (29 shared papers)Paul M. Schneider (55 shared papers)Arnulf H. Hölscher (39 shared papers)Daniel Vallböhmer (48 shared papers)Dennis Salonga (13 shared papers)Reginald V. Lord (14 shared papers)
- Journals
- Journal of Gastrointestinal Surgery (8 papers)Gastroenterology (5 papers)Journal of Surgical Oncology (5 papers)Journal of Clinical Oncology (5 papers)Clinical Lung Cancer (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Jan Brabender
98 papers receiving 4.5k citations
Jan Brabender's Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 1.5k
- Cancer Research 633
- Pulmonary and Respiratory Medicine 1.2k
- Surgery 1.0k
- Molecular Biology 1.6k
Countries citing papers authored by Jan Brabender
This map shows the geographic impact of Jan Brabender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Brabender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Brabender more than expected).
Fields of papers citing papers by Jan Brabender
This network shows the impact of papers produced by Jan Brabender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Brabender. The network helps show where Jan Brabender may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Brabender, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Hit paper breakdown → | 2002 | 550 |
| 2 | ERCC1 and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil Chemotherapy Hit paper breakdown → | 2001 | 512 |
| 3 | Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival. | 2001 | 407 |
| 4 | Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. | 2002 | 255 |
| 5 | Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. | 2001 | 192 |
| 6 | 2008 | 126 | |
| 7 | 2008 | 125 | |
| 8 | 2001 | 114 | |
| 9 | 2009 | 102 | |
| 10 | 2002 | 101 | |
| 11 | 2004 | 91 | |
| 12 | Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome. | 2003 | 87 |
| 13 | 2004 | 63 | |
| 14 | 2005 | 61 | |
| 15 | 2005 | 57 | |
| 16 | 2004 | 56 | |
| 17 | Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexed. | 2003 | 56 |
| 18 | 2006 | 56 | |
| 19 | 2004 | 52 | |
| 20 | 2005 | 52 |
About Jan Brabender
Jan Brabender is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Pathology and Forensic Medicine, having authored 100 papers that have together received 4.6k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (35 papers), Gastric Cancer Management and Outcomes (13 papers), Esophageal and GI Pathology (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Epigenetics and DNA Methylation (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer-related gene regulation (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (633 citations), Pulmonary and Respiratory Medicine (1.2k citations), Surgery (1.0k citations) and Molecular Biology (1.6k citations). Jan Brabender has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Kathleen D. Danenberg, Ralf Metzger, Peter V. Danenberg, Paul M. Schneider, Arnulf H. Hölscher, Daniel Vallböhmer, Dennis Salonga, Reginald V. Lord, A. H. Hölscher and Hiroyuki Uetake. Their work appears in journals such as Journal of Gastrointestinal Surgery, Gastroenterology, Journal of Surgical Oncology, Journal of Clinical Oncology and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.